Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Anoxic Brain Injury: An Underreported and Oftentimes Overlooked Consequence of Overdose

    by
    • Dr. Robert Hall
    | May 23, 2017
    Tag Icon
    Opioids, Naloxone
    A few weeks back, a new patient of mine was accompanied into the examination room by his daughter. Although he was in his mid-50’s, he needed a significant amount of assistance due to decreased balance and unsteady walking. The reason for the referral was to evaluate the cause of his right shoulder and neck pain and hand numbness, which were ultimately found to be due to a pinched nerve. While we were discussing his symptoms, I asked if he had ever been treated for a brain injury.


  • To Be or Not to Be – the Fate of the Louisiana Workers’ Compensation Drug Formulary

    by
    • Optum Workers' Comp
    | May 18, 2017
    Tag Icon
    Formularies, Opioids, PDMPs
    The debate over a drug formulary for the Louisiana workers’ compensation system rages on in the halls of the capitol in Baton Rouge. In one of the latest turns, the Workforce Commission and the Office of Workers’ Compensation Administration made a joint public proclamation opposing drug formularies as “unproven” and “unnecessary”, suggesting instead that other proposed controls will reduce the prescribing of opioids. The proposed controls would cover all sectors of the healthcare system and are not specific to workers’ compensation. The controls include a recommended seven-day limit for initial opioid prescriptions and the mandatory review of the patient’s Schedule II medication history in the state’s prescription drug monitoring program. While we agree these controls will have an impact, we think it is important to engage every reasonable tool at our disposal to combat the current opioid epidemic.


  • Federal Workers’ Compensation Programs Adopt Opioid Policies

    by
    • Optum
    | May 17, 2017
    Tag Icon
    Opioids
    The Division of Federal Employee’s Compensation (DFEC) recently announced policy changes aimed at better managing and monitoring the usage of opioid medications utilized in treating Federal workers’ compensation claimants covered under their program. The policy changes will be implemented in phases, in August, and starting in August, and will apply to all Federal Employee Compensation Act (FECA) claimants where an opioid analgesic has not previously been prescribed within the last 180 days, if ever. Under the new policy, any prescribed opioid analgesic will be limited to a 60-day supply.


  • Florida Takes Regulatory Action On Compounds

    by
    • Optum Workers' Comp
    | May 11, 2017
    Tag Icon
    Compounded Medications
    The Florida Division of Workers’ Compensation (DWC) has adopted changes to their 2016 Healthcare Provider Reimbursement Manual implementing new requirements for the dispensing and reimbursement of compounded medications.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.